BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23838570)

  • 1. USDA regulatory guidelines and practices for veterinary Leptospira vaccine potency testing.
    Srinivas GB; Walker A; Rippke B
    Biologicals; 2013 Sep; 41(5):298-302. PubMed ID: 23838570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of in vitro assays for measuring the relative potency of leptospiral bacterins containing serogroups canicola, grippotyphosa, icterohaemorrhagiae, and pomona.
    Ruby KW; Srinivas GB
    Biologicals; 2013 Sep; 41(5):308-14. PubMed ID: 23870804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
    Walker A; Srinivas GB
    Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating the LD50 requirements in the codified potency testing of veterinary vaccines containing Leptospira (L.) serogroup Icterohaemorrhagiae and L. serogroup Canicola in the United States.
    Walker A; Olsen R; Toth M; Srinivas G
    Biologicals; 2018 Nov; 56():13-18. PubMed ID: 30126631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.
    Draayer HA; Bruckner L; Peña-Moctezuma Ade L; Srinivas G
    Biologicals; 2013 Sep; 41(5):305-7. PubMed ID: 23890730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the in vitro assay for Leptospira potency testing to other serovars: case study with Leptospira Hardjo.
    Alt DP; Wilson-Welder J
    Biologicals; 2013 Sep; 41(5):323-4. PubMed ID: 23838569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European regulatory framework and practices for veterinary Leptospira vaccine potency testing.
    Bruckner L
    Biologicals; 2013 Sep; 41(5):303-4. PubMed ID: 23886926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful development and validation of an in vitro replacement assay for Leptospira vaccine potency tests.
    Kulpa-Eddy J
    Dev Biol (Basel); 2012; 134():101-6. PubMed ID: 22888601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.
    Stokes W; Srinivas G; McFarland R; Kulpa-Eddy J; Casey W; Walker A; Draayer H; Sebring R; Brown K; Balks E; Stirling C; Klaasen E; Hill R; Rippke B; Ruby K; Alt D; Mukhopadhyay S; Kojima H; Johnson N; Rinckel L; Doelling V; Jones B
    Biologicals; 2013 Sep; 41(5):279-94. PubMed ID: 23890729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vaccination of cattle with the Leptospira interrogans serovar hardjo type hardjoprajitno component of a pentavalent Leptospira bacterin against experimental challenge with Leptospira borgpetersenii serovar hardjo type hardjo-bovis.
    Rinehart CL; Zimmerman AD; Buterbaugh RE; Jolie RA; Chase CC
    Am J Vet Res; 2012 May; 73(5):735-40. PubMed ID: 22533408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Product-specific validation of a serological potency test for release of Leptospira vaccines in the European Union.
    Stirling C; Novokova V
    Biologicals; 2013 Sep; 41(5):330-1. PubMed ID: 23849308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Leptospira in vitro potency assays: EU/industry experience and perspectives.
    Klaasen HL; van der Veen M; Molkenboer MJ; Bruderer U
    Biologicals; 2013 Sep; 41(5):315-22. PubMed ID: 23867758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of in vivo leptospirosis vaccine potency testing in the United States.
    Rogers B; Brown J; Allen DG; Casey W; Clippinger AJ
    Biologicals; 2022 Jul; 78():36-44. PubMed ID: 35753962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the immune response of cattle to leptospiral bacterins.
    Tripathy DN; Hanson LE; Mansfield ME
    Am J Vet Res; 1976 Jan; 37(1):51-5. PubMed ID: 1247197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to leptospirosis: Leptospira interrogans serotype pomona bacterins in cattle.
    Huhn RG; Hanson LE; Killinger AH; Cardella MA
    Am J Vet Res; 1975 Jan; 36(1):59-65. PubMed ID: 1115419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine Immune Response to Vaccination and Infection with Leptospira borgpetersenii Serovar Hardjo.
    Wilson-Welder JH; Alt DP; Nally JE; Olsen SC
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33762318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a serological potency test for the release of Leptospira vaccines--requirements in the European Union.
    Balks E; Gyra H; Kobe B; Cussler K; Werner E
    Biologicals; 2013 Sep; 41(5):325-9. PubMed ID: 23911253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of cellular and whole-culture leptospiral bacterins.
    Nazier AA; Ewais MA
    J Egypt Public Health Assoc; 1997; 72(3-4):369-77. PubMed ID: 17216994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth response and shedding of Leptospira spp. in urine following vaccination for leptospirosis in young farmed deer.
    Subharat S; Wilson PR; Heuer C; Collins-Emerson JM
    N Z Vet J; 2012 Jan; 60(1):14-20. PubMed ID: 22175424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of serum antibodies against six Leptospira serovars in healthy dogs.
    Stokes JE; Kaneene JB; Schall WD; Kruger JM; Miller R; Kaiser L; Bolin CA
    J Am Vet Med Assoc; 2007 Jun; 230(11):1657-64. PubMed ID: 17542733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.